Cullinan Therapeutics, Inc. (CGEM)
11.39
+0.59
(+5.46%)
USD |
NASDAQ |
Nov 06, 15:30
Cullinan Therapeutics Net Income (TTM) : -204.69M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -204.69M |
| March 31, 2026 | -221.04M |
| December 31, 2025 | -219.88M |
| September 30, 2025 | -216.81M |
| June 30, 2025 | -206.76M |
| March 31, 2025 | -178.74M |
| December 31, 2024 | -167.58M |
| September 30, 2024 | -145.49M |
| June 30, 2024 | -144.11M |
| March 31, 2024 | -134.30M |
| December 31, 2023 | -155.10M |
| September 30, 2023 | -156.63M |
| June 30, 2023 | -142.33M |
| Date | Value |
|---|---|
| March 31, 2023 | 63.95M |
| December 31, 2022 | 109.20M |
| September 30, 2022 | 102.08M |
| June 30, 2022 | 108.71M |
| March 31, 2022 | -81.80M |
| December 31, 2021 | -67.48M |
| September 30, 2021 | -62.38M |
| June 30, 2021 | -55.44M |
| March 31, 2021 | -52.88M |
| December 31, 2020 | -59.46M |
| September 30, 2020 | -35.08M |
| June 30, 2020 | -30.62M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Climb Bio, Inc. | -57.62M |
| MapLight Therapeutics, Inc. | -229.83M |
| Arrowhead Pharmaceuticals, Inc. | -272.12M |
| Oncolytics Biotech, Inc. | -30.07M |
| Sangamo Therapeutics, Inc. | -123.33M |